Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Cell & Gene Therapy

Stem cell research and commercialization in China...

NeuShen and UMass Partner To Develop Gene Therapy for ALS

Help Therapeutics to Start Trial of Universal Cell Therapy for Heart Failure

HuidaGene’s CRISPR Therapy Approved to Start US Trial for Inherited Retinal Disease

Nanjing IASO Bio Raises $75 Million to Develop/Commercialize CAR-T Assets

GenScript ProBio -- a mAb, Cell & Gene Therapy CDMO -- Raises $224 Million

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China